Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

BACKGROUND: As the use of Integrase inhibitor (INSTI)-class antiretroviral medications becomes more common to maintain long-term viral suppression, early reports suggest the potential for CNS side-effects when starting or switching to an INSTI-based regimen. In a population already at higher risk fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIDS Behav
Autors principals: Kamkwalala, Asante R., Wang, Kunbo, O’Halloran, Jane, Williams, Dionna W., Dastgheyb, Raha, Fitzgerald, Kathryn C., Spence, Amanda B., Maki, Pauline M., Gustafson, Deborah R., Milam, Joel, Sharma, Anjali, Weber, Kathleen M., Adimora, Adaora A., Ofotokun, Igho, Sheth, Anandi N., Lahiri, Cecile D., Fischl, Margaret A., Konkle-Parker, Deborah, Xu, Yanxun, Rubin, Leah H.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948485/
https://ncbi.nlm.nih.gov/pubmed/32638219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02967-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars